>>> GSK - Forecasts FX impact in Q4 sales at -3%; FY14 FX impact at -7%, to main Forecasts FX impact in Q4 sales at -3%; FY14 FX impact at -7%, to maintain 2015 dividend at same level as 2014 - press - FX impact to have stronger impact on EPS than on sales